India gets around 68% of its raw materials — known as active pharmaceutical ingredients (APIs) — from China. Any disruption in that supply chain can create a major problem, especially during a pandemic.
The coronavirus exposed US reliance on India for generic drugs. That supply chain all hinges on China
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over